Thapa B, Caimi PF, Ardeshna KM, et al. CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. Blood Adv. 2020;4(16):3850-3852.

In the author affiliations on page 3850, Carmelo Carlo-Stella’s affiliation should read, “Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas University, Rozzano, Milan, Italy.” In addition, on page 3852, this author’s ORCID profile was omitted. The errors have been corrected in the published article.